Susan Hasty, Publisher
Table of Contents . . . June 30th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Vaccine Week | Other Publications
At-Risk Populations - Study will evaluate recombinant canarypox HIV-1 vaccine in IV drug users
Etiology - Research sheds further light on the origins of HIV-1
AIDS Vaccine - Company presents preclinical results from AIDS vaccine program
HIV/AIDS Vaccine - Systemic priming with mucosal boosting shows promise in animals
Therapeutic Vaccines - Patent granted for herpes vaccine; peptide may be used as adjuvant for vaccines
AIDS Drug Prices - Drug giant urged to resolve pricing battle
AIDS Education - National organizations applaud educational initiative
AIDS-related Lymphoma - HAART appears to have caused biological shift towards more treatable disease
Disease Transmission - Study suggests prevalent anal sex in Sub-Saharan Africa key in HIV spread
HIV/AIDS Education - New program helps people with HIV communicate with healthcare providers
HIV/AIDS Therapy - Enfuvirtide is first fusion inhibitor for treating patients with HIV
HIV/AIDS Therapy - Lactic acidosis risk factors during NRTI treatment identified
HIV/AIDS Therapy - Monopyrrolinone-based HIV-1 protease inhibitors developed
HIV/AIDS Therapy - Natural compounds inhibit viral promoter activity
HIV/AIDS Therapy - Nordihydroguaiaretic acid derivative inhibits viral Tat function
HIV/AIDS Therapy - Novel octapeptide has antiviral activity in cats
HIV/AIDS Therapy - Novel plant extracts have antiviral activity
HIV/AIDS Therapy - SL1 RNA stem may be therapeutic target
HIV/AIDS Therapy - Technique exploits aptamer-gp120 interactions to identify new antiretrovirals
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.